Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".
作者信息
Outeiro Tiago F, Krisko Anita
机构信息
Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Goettingen, Goettingen, Germany.
Max Planck Institute for Experimental Medicine, Goettingen, Germany.
出版信息
Mov Disord. 2021 Feb;36(2):278-279. doi: 10.1002/mds.28482.
Abstract
摘要
相似文献
1
Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".回复：《帕金森病与2019冠状病毒病：我们需要更有耐心吗？》
Mov Disord. 2021 Feb;36(2):278-279. doi: 10.1002/mds.28482.
2
Parkinson's Disease and COVID-19: Do We Need to Be More Patient?帕金森病与2019冠状病毒病：我们需要更有耐心吗？
Mov Disord. 2021 Feb;36(2):277. doi: 10.1002/mds.28469.
3
Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
Mov Disord. 2020 Sep;35(9):1498. doi: 10.1002/mds.28211.
4
In reply to: Helmich and Bloem (2020) "The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities".回复：赫尔米奇和布洛姆（2020年）《2019冠状病毒病大流行对帕金森病的影响：隐藏的痛苦与新出现的机遇》
J Parkinsons Dis. 2020;10(3):1267-1268. doi: 10.3233/JPD-202169.
5
Reply to: "Can the 2019 Novel Coronavirus Cause Parkinson's Disease?".回复：“2019新型冠状病毒会引发帕金森病吗？”
Mov Disord. 2020 Oct;35(10):1726. doi: 10.1002/mds.28245.
6
COVID-19 in Parkinson's disease: Report on prevalence and outcome.帕金森病中的新型冠状病毒肺炎：患病率及预后报告。
Parkinsonism Relat Disord. 2020 Nov;80:7-9. doi: 10.1016/j.parkreldis.2020.09.008. Epub 2020 Sep 6.
7
Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study.帕金森病患者中新型冠状病毒2型的血清流行率：一项病例对照研究。
Mov Disord. 2021 Apr;36(4):794-795. doi: 10.1002/mds.28580. Epub 2021 Mar 17.
8
Impact of home confinement during COVID-19 pandemic on Parkinson's disease.新冠疫情期间居家隔离对帕金森病的影响。
Parkinsonism Relat Disord. 2020 Nov;80:32-34. doi: 10.1016/j.parkreldis.2020.09.003. Epub 2020 Sep 6.
9
Is COVID-19 a Perfect Storm for Parkinson's Disease?COVID-19 是否是帕金森病的完美风暴？
Trends Neurosci. 2020 Dec;43(12):931-933. doi: 10.1016/j.tins.2020.10.009. Epub 2020 Oct 21.
10
Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
Mov Disord. 2020 Sep;35(9):1497. doi: 10.1002/mds.28213.
引用本文的文献
1
Neurological complications caused by SARS-CoV-2.新型冠状病毒（SARS-CoV-2）引起的神经并发症。
Clin Microbiol Rev. 2024 Dec 10;37(4):e0013124. doi: 10.1128/cmr.00131-24. Epub 2024 Sep 18.
2
SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now.严重急性呼吸综合征冠状病毒2与帕金森病：对当前进展的综述
Biomedicines. 2023 Sep 13;11(9):2524. doi: 10.3390/biomedicines11092524.
3
Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.通过蛋白质-蛋白质相互作用从严重急性呼吸综合征冠状病毒2型关联到帕金森病
Viruses. 2021 May 12;13(5):897. doi: 10.3390/v13050897.
本文引用的文献
1
Parkinson's Disease and COVID-19: Do We Need to Be More Patient?帕金森病与2019冠状病毒病：我们需要更有耐心吗？
Mov Disord. 2021 Feb;36(2):277. doi: 10.1002/mds.28469.
2
Is COVID-19 a Perfect Storm for Parkinson's Disease?COVID-19 是否是帕金森病的完美风暴？
Trends Neurosci. 2020 Dec;43(12):931-933. doi: 10.1016/j.tins.2020.10.009. Epub 2020 Oct 21.
3
SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime.严重急性呼吸综合征冠状病毒2、免疫衰老与炎症衰老：新冠疫情中的“共犯”
Aging (Albany NY). 2020 Sep 29;12(18):18778-18789. doi: 10.18632/aging.103989.
4
A case of probable Parkinson's disease after SARS-CoV-2 infection.1例新型冠状病毒感染后可能患帕金森病的病例。
Lancet Neurol. 2020 Oct;19(10):804-805. doi: 10.1016/S1474-4422(20)30305-7. Epub 2020 Sep 16.
5
Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case.2019冠状病毒病与帕金森综合征：1例非脑炎后病例
Mov Disord. 2020 Oct;35(10):1721-1722. doi: 10.1002/mds.28277. Epub 2020 Sep 24.
6
SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration.严重急性呼吸综合征冠状病毒2：处于衰老与神经退行性变的十字路口
Mov Disord. 2020 May;35(5):716-720. doi: 10.1002/mds.28084. Epub 2020 Apr 24.
7
Protein damage, ageing and age-related diseases.蛋白质损伤、衰老和与年龄相关的疾病。
Open Biol. 2019 Mar 29;9(3):180249. doi: 10.1098/rsob.180249.
8
Encephalitis lethargica: 100 years after the epidemic.昏睡性脑炎：疫情爆发100年后。
Brain. 2017 Aug 1;140(8):2246-2251. doi: 10.1093/brain/awx177.
9
Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.慢性炎症（炎症衰老）及其对与年龄相关疾病的潜在贡献。
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9. doi: 10.1093/gerona/glu057.
10
Age-related changes in oxidized proteins.氧化蛋白质的年龄相关变化。
J Biol Chem. 1987 Apr 25;262(12):5488-91.
Zotero 插件